Related references
Note: Only part of the references are listed.Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
Lauren B. Rodda et al.
CELL (2021)
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
Erik Volz et al.
CELL (2021)
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
Drew Weissman et al.
CELL HOST & MICROBE (2021)
Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020
Kathy Leung et al.
EUROSURVEILLANCE (2021)
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial
Robert L. Gottlieb et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
Summer E. Galloway et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Comparison of Four SARS-CoV-2 Neutralization Assays
Lydia Riepler et al.
VACCINES (2021)
Evidence of Novel SARS-CoV-2 Variants Circulation in Romania
Marius Surleac et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2021)
Syncytia formation by SARS-CoV-2-infected cells (vol 39, e106267, 2020)
Julian Buchrieser et al.
EMBO JOURNAL (2021)
S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction
Michael Kidd et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Importation of SARS-CoV-2 Variant B.1.1.7 in Pakistan
Massab Umair et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis
Shi Zhao et al.
JOURNAL OF TRAVEL MEDICINE (2021)
Isolation and characterization of the new SARS-CoV-2 variant in travellers from the United Kingdom to India: VUI-202012/01 of the B.1.1.7 lineage
Pragya D. Yadav et al.
JOURNAL OF TRAVEL MEDICINE (2021)
SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation
Bojan F. Hoernich et al.
JOURNAL OF VIROLOGY (2021)
NOVAVAX OFFERS FIRST EVIDENCE THAT COVID VACCINES PROTECT PEOPLE AGAINST VARIANTS
Ewen Callaway et al.
NATURE (2021)
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Xuping Xie et al.
NATURE MEDICINE (2021)
Neutralizing Activity of BNT162b2-Elicited Serum
Yang Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera
Alexander Muik et al.
SCIENCE (2021)
Detection of B.1.351 SARS-CoV-2 Variant Strain - Zambia, December 2020
Mulenga Mwenda et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil
Ronaldo da Silva Francisco Jr et al.
VIRUS RESEARCH (2021)
Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020
Ingra Morales Claro et al.
EMERGING INFECTIOUS DISEASES (2021)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
Markus Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Vanessa Monteil et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Shuai Xia et al.
CELL RESEARCH (2020)
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
Markus Hoffmann et al.
MOLECULAR CELL (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum et al.
SCIENCE (2020)
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna Hansen et al.
SCIENCE (2020)
Distinct conformational states of SARS-CoV-2 spike protein
Yongfei Cai et al.
SCIENCE (2020)
Broad and strong memory CD4+and CD8+T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Yanchun Peng et al.
NATURE IMMUNOLOGY (2020)
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
Alina Baum et al.
SCIENCE (2020)
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Ania Wajnberg et al.
SCIENCE (2020)
Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization
Hannah Kleine-Weber et al.
JOURNAL OF VIROLOGY (2019)
Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein
Hannah Kleine-Weber et al.
SCIENTIFIC REPORTS (2018)
The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells
Constantin Brinkmann et al.
PLOS ONE (2017)
TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
Adeline Heurich et al.
JOURNAL OF VIROLOGY (2014)
Characterization of the Sialic Acid Binding Activity of Influenza A Viruses Using Soluble Variants of the H7 and H9 Hemagglutinins
Anne-Kathrin Sauer et al.
PLOS ONE (2014)
Differential Sensitivity of Bat Cells to Infection by Enveloped RNA Viruses: Coronaviruses, Paramyxoviruses, Filoviruses, and Influenza Viruses
Markus Hoffmann et al.
PLOS ONE (2013)
Inhibition of Influenza Virus Infection in Human Airway Cell Cultures by an Antisense Peptide-Conjugated Morpholino Oligomer Targeting the Hemagglutinin-Activating Protease TMPRSS2
Eva Boettcher-Friebertshaeuser et al.
JOURNAL OF VIROLOGY (2011)
A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon
Marianne Berger Rentsch et al.
PLOS ONE (2011)
The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus
Abraham L. Brass et al.
CELL (2009)
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes
B Bartosch et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)